Company officer · Companies House register
Christopher Philip Ashton
6 current appointments and 9 former, as recorded on the register.
Current appointments
- Omass Therapeutics Limited
Director · since Oct 2020
- PULMAGEN THERAPEUTICS LLP
LLP designated member · since Feb 2010 · Dissolved
- PULMAGEN THERAPEUTICS (INFLAMMATION) LIMITED
Director · since Jan 2010 · Dissolved
- PULMAGEN THERAPEUTICS (HOLDINGS) LIMITED
Director · since Oct 2008 · Dissolved
- PULMAGEN THERAPEUTICS (SYNERGY) LIMITED
Director · since Oct 2004 · Dissolved
- ETIOLOGICS LIMITED
Director · since Oct 2002 · Dissolved
Former appointments
- T-Cypher Bio Holdings Limited
Director · Jan 2023 – Feb 2024
- T-Cypher Bio Limited
Director · Jan 2023 – Feb 2024
- MACROPHOX LTD
Director · Feb 2019 – Jul 2020 · Dissolved
- ACHILLES THERAPEUTICS UK LIMITED
Director · May 2016 – Jan 2018 · Liquidation
- PULMAGEN THERAPEUTICS (ASTHMA) LIMITED
Director · Oct 2008 – Sept 2017 · Dissolved
- SYNCONA MANAGEMENT LLP
LLP member · Apr 2016 – Dec 2016 · Dissolved
- SYNCONA PARTNERS LLP
LLP member · Apr 2016 – Dec 2016 · Dissolved
- ARGENTA DISCOVERY 2009 LIMITED
Director · Jul 2009 – Feb 2010 · Dissolved
- Orchid Cellmark Ltd
Director · Sept 2000 – Sept 2002
−£6.63m
Loss after tax
From the Companies House register, checked 2026-11-07. Names, roles and dates only; contains public sector information licensed under the Open Government Licence v3.0. Profit is each company's latest filed figure. Appointments under other records of the same person may be listed separately.
Is this you? To ask for a correction or to object, see our privacy notice or write to support@firmfacts.co.